Giant Cell Tumor




CLINICAL SUMMARY


Giant cell tumor of bone is a benign but destructive bone tumor that is usually discovered adjacent to the knee joint in young adults. Although curettage is the most common treatment, it is nevertheless associated with a relatively high local recurrence rate. Despite the benign designation, a small percentage of patients (fewer than 2%) develop lung metastases.




DIAGNOSTIC FEATURES





















History


  • Most common in young adults, 20 to 30 years of age; 80% occur between 20 and 50 years of age



  • Rare in children younger than 14 years of age (1% to 3%)



  • Pain and swelling, often increased by activity



  • Gradually worsening over 3 to 6 months

Location


  • Metaphyseal, eccentric



  • Originates in the metaphysis and extends into the epiphysis, often to subchondral bone



  • Distribution: about the knee (50% to 65%), distal radius (10% to 12%), proximal humerus (4% to 8%), anterior spine (7% to 15%); in the spine, the prevalence is sacrum > thoracic > cervical > lumbar

Margins


  • Geographic lysis



  • Narrow zone of transition in 85% of lesions, 20% with thin rim of sclerosis, usually more evident on CT



  • Infrequently (15%) can have a wide zone of transition

Matrix


  • No matrix mineralization






IMAGING




























  • Typical giant cell tumor, presenting as an eccentric metaphyseal lytic lesion, extending to subchondral bone as seen in the distal femur ( left ) and distal radius ( right ).



  • Geographic lysis with a wide zone of transition and absence of matrix mineralization is seen in both lesions. Internal septations, which are thickened trabeculae, are more prominent in the radius lesion.










  • In some cases, a thin sclerotic rim is visible, as seen in this proximal tibia lesion ( left ).



  • The more common appearance on radiographs is geographic lysis without a sclerotic rim, as seen in this proximal femur lesion ( right ).


Get Clinical Tree app for offline access